MIZUHO SECURITIES USA LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 40 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MIZUHO SECURITIES USA LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2022$2,264,000
+55.1%
1,600,000
+45.5%
0.31%
+37.5%
Q2 2022$1,460,000
+6.9%
1,100,000
+5.6%
0.22%
+14.9%
Q1 2022$1,366,000
-17.8%
1,042,000
+4.2%
0.20%
+74.1%
Q2 2020$1,661,000
-71.0%
1,000,000
-73.3%
0.11%
-60.4%
Q4 2019$5,729,0003,742,0000.28%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders